ARTICLE | Distillery Therapeutics
Therapeutics: Chemokine CC motif ligand 7 (CCL7; MCP3; SCYA6); CC chemokine receptor 3 (CCR3; CD193)
January 28, 2016 8:00 AM UTC
Patient sample, cell culture and mouse studies suggest inhibiting CCL7-CCR3 signaling could help treat prostate cancer. In patients with prostate cancer, tumor levels of CCR3 correlated with disease r...